drugset / Trial / NCT01615354
A Study of Aleglitazar in Combination With Oral Contraceptive Healthy Volunteers
RandomizedCrossoverDouble-blind
Summary
This randomized, double-blind, placebo-controlled, cross-over study will assess the effect of aleglitazar on the pharmacokinetics and pharmacodynamics on Microgynon® in healthy volunteers. Volunteers will receive multiple oral doses of aleglitazar in one period; in the other period volunteers will receive placebo.
Timeline
- Start
- 2012-07
- Primary completion
- 2013-01
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Microgynon | Unknown | — | Oral |
| Subject | aleglitazar | Small molecule | — | Oral |
Indications
No indication recorded.